![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Biol Chem, Vol. 275, Issue 18, 13406-13410, May 5, 2000
From the Department of Biochemistry and Molecular Biology and Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana 46202
| |
ABSTRACT |
|---|
|
|
|---|
Guanine nucleotide exchange factors (GEFs) are
responsible for coupling cell surface receptors to Ras protein
activation. Here we describe the characterization of a novel family of
differentially expressed GEFs, identified by database sequence homology
searching. These molecules share the core catalytic domain of other Ras
family GEFs but lack the catalytic non-conserved (conserved
non-catalytic/Ras exchange motif/structurally conserved region 0)
domain that is believed to contribute to Sos1 integrity. In
vitro binding and in vivo nucleotide exchange assays
indicate that these GEFs specifically catalyze the GTP loading of the
Ral GTPase when overexpressed in 293T cells. A central proline-rich
motif associated with the Src homology (SH)2/SH3-containing adapter
proteins Grb2 and Nck in vivo, whereas a pleckstrin
homology (PH) domain was located at the GEF C terminus. We refer to
these GEFs as RalGPS 1A, 1B, and 2 (Ral GEFs with PH domain and SH3
binding motif). The PH domain was required for in vivo GEF
activity and could be functionally replaced by the Ki-Ras C terminus,
suggesting a role in membrane targeting. In the absence of the PH
domain RalGPS 1B cooperated with Grb2 to promote Ral activation,
indicating that SH3 domain interaction also contributes to RalGPS
regulation. In contrast to the Ral guanine nucleotide dissociation
stimulator family of Ral GEFs, the RalGPS proteins do not possess a
Ras-GTP-binding domain, suggesting that they are activated in a
Ras-independent manner.
The Ras family of GTPases plays a key role in integrating and
transmitting signals from cell surface receptors to downstream effector
pathways (1-3). Ras proteins exist predominantly in their inactive
GDP-bound state in resting cells. However, upon activation by
extracellular stimuli guanine nucleotide exchange factors
(GEFs)1 promote the release
of GDP from Ras, permitting GTP, which is present in molar excess in
the cytoplasm, to associate with Ras (1, 2). This GTP-bound Ras adopts
an active conformation and signals to downstream effector proteins such
as Raf, phosphoinositide 3-kinase, and RalGDS (reviewed in Ref. 1).
GTPase-activating proteins (GAPs) subsequently enhance the intrinsic
GTPase activity of Ras resulting in its rapid return to the inactive
GDP-bound state.
In addition to the classic Ha-, Ki-, and N-Ras proteins, ~15 other
GTPases make up the Ras sub-group of the Ras superfamily. These include
R-Ras, TC21/R-Ras2, M-Ras/R-Ras3, RalA and B, Rap1A and B, Rap2A and B,
Rit, Rin, Rheb, Rhes, and Dex-Ras (1). Although the function of many of
these GTPases remains to be determined, they are presumably all
regulated by a similar GDP/GTP cycle to Ras. However, only a limited
number of Ras GEFs have so far been identified that regulate Ras family
GTPases; Sos, GRF and GRP for Ras, C3G, CalDAG1 and Epac for Rap1, and
RalGDS family members for Ral (2-7).
The catalytic domains of mammalian Ras GEFs share approximately 30%
homology with each other and the Saccharomyces
cerevisiae CDC25 (2, 8). In an attempt to identify the
upstream GEFs and extracellular ligands responsible for the activation
of Ras sub-family GTPases we searched the National Center for
Biotechnology Information DNA sequence databases for novel cDNAs
sharing catalytic domain homology with existing Ras family GEFs. We
identified a family of GEFs that contain a catalytic/CDC25 homology
domain, a proline-rich PXXP motif similar to SH3 domain
binding motifs (9), and a C-terminal pleckstrin homology domain (10).
Here we demonstrate that this family of GEFs promotes GTP loading of the Ral GTPase in vivo, binds to the SH3 domain-containing
adapter proteins, Grb2 and Nck, and requires their PH domain for
bioactivity. We refer to these exchange factors as RalGPS for
Ral/PH/SH3-binding GEFs. The RalGDS family of Ral GEFs (consisting of
RalGDS, Rgl, and Rgl2/Rlf) are downstream effectors of Ras (1).
However, because of the lack of a Ras-binding RA (RalGDS/AF6 homology
or Ras-associated) domain (11, 12) it is anticipated that this new Ral
GEF family is regulated independently of Ras activation.
Plasmid Constructs--
RalGPS 1A partial cDNA was obtained
as a human expressed sequence tag (EST) clone (AA121710). Further
sequence was obtained by 5' RACE using nested primers and a
Marathon-ReadyTM human heart cDNA library
(CLONTECH). ClaI and BamHI
sites were incorporated immediately 5' of the presumed start codon by
polymerase chain reaction, and RalGPS 1A
(ClaI-XhoI) was inserted into the pFLAG-CMV2 vector (Eastman Kodak Co.), creating FLAG-RalGPS 1A. Full-length human
RalGPS 1B (KIAA0351) was obtained from Kazusa DNA Research Institute,
Chiba, Japan. The FLAG-tagged construct was prepared by purifying the
XbaI-SmaI fragment of RalGPS 1B and inserting it
into the XbaI-SmaI site of pFLAG-CMV2 RalGPS 1A
from above. The C termini (residues 392-529 and 433-557 for RalGPS 1A
and B, respectively) encompassing the PH domain were removed from RalGPS 1A/B by digesting with NcoI, blunting, and inserting
the fragment (ClaI-NcoI/blunt) into the
ClaI-EcoRV sites of pFLAG-CMV2. The
CAAX construct was generated by inserting the above
(ClaI-NcoI/blunt) fragment into the
ClaI-EcoRV sites of pE-CAAX vector
(created by G. Clark, NCI, National Institutes of Health). RalGPS
1A/B-
Ral, Rap2B, and Rheb were generously provided by D. Andres (University
of Kentucky), J. de Gunzburg (Institut Curie, Paris, France), and G. Clark (NCI, National Institutes of Health), respectively. Rlf and the
pGEX-RID (Ral interacting domain from RalBP1, residues 648-778) were
provided by D. Andres. C3G was obtained from S. Tanaka and H. Hanafusa
(Rockefeller University). SH3 domain-encoding plasmids have previously
been described (13, 14).
Production and Purification of GST Fusion Proteins--
GST
fusion proteins were expressed in E. coli strain
BL21-DE3(lysE). Bacteria were lysed using a French press in 20 mM Tris-HCl, pH 8.0, 500 mM NaCl, 1% Triton
X-100, 1 mM EDTA, 1 mM PMSF, and aprotinin
(0.05 TIU/ml). For GTPases, 10 µM GDP and 1 mM MgCl2 were added in place of EDTA. The
lysate was cleared by centrifugation (10,000 × g, 10 min, 4 °C) and tumbled with glutathione-agarose beads (Sigma). Beads
were washed with 20 mM Tris-HCl, pH 8.0, 20% glycerol, 1 mM DTT, 50 mM NaCl, 1 mM PMSF, and
1 mM EDTA (or 5 mM MgCl2 and 10 µM GDP for GTPases) and stored at 4 °C as a 50%
slurry containing 0.02% NaN3 (w/v).
Miscellaneous--
A 1.5-kb XbaI-XhoI
fragment from RalGPS 1A was radiolabeled with [32P]dCTP
and used to probe human multitissue Northern blots
(CLONTECH) as described previously (13). 293T human
embryonic kidney cells were cultured as described (13). SH3 binding
assays were performed essentially as described (14).
Ras Protein Binding Assay--
Three 100-mm dishes of 70%
confluent 293T cells were transfected with 7.5 µg of FLAG-RalGPS 1A/B
using 15 µg of NovaFECTOR/dish (Venn Nova Inc.) following the
manufacturer's directions. After 72 h, cells were lysed (1 ml/100-mm dish) in 20 mM Tris-HCl, pH 7.4, 1% IGEPAL
(Sigma), 1 mM EDTA, 100 mM NaCl, 0.05 TIU/ml of aprotinin, and 1 mM PMSF. Ras-bound beads containing ~20
µg of protein were mixed with empty glutathione-agarose beads (50%
slurry) to give a final volume of 35 µl. The beads were rinsed twice
with 1 ml of Ras buffer (20 mM Tris-HCl, pH 7.6, 5%
glycerol, 50 mM NaCl, 0.1% Triton X-100, and 1 mM DTT) and then incubated with the Ras buffer spiked with
10 mM EDTA for 10 min at room temperature. Approximately
400 µl of cell lysate containing FLAG-RalGPS 1A/B was added to the
rinsed Ras-bound beads. This slurry was tumbled for 2 h at 4 °C
and then the beads were washed 4 times with Ras buffer supplemented
with EDTA to 5 mM.
In Vivo Exchange Assay--
293T cells were transfected with 750 ng of pFLAG-CMV2-RalA and 750 ng of the indicated GEF using 8 µl of
NovaFECTOR/60-mm dish. After 24 h, serum was removed for another
18 h. Cells were rinsed twice in phosphate buffered saline, lysed
with Ral buffer (0.5 ml/dish; 50 mM Tris-HCl, pH 7.4, 10%
glycerol, 200 mM NaCl, 2.5 mM
MgCl2, 1% IGEPAL (Sigma), aprotinin (0.05 TIU/ml), 1 mM PMSF), and cleared by centrifugation for 10 min at
12,000 rpm. Approximately 10 µg of GST-RID or -Raf (residues 2-140)
bound to 35 µl of glutathione-agarose beads (50% slurry) were rinsed twice with Ral buffer and then tumbled with 400 µl of cell lysate for
1 h at 4 °C. The beads were washed 4 times with Ral buffer, omitting protease inhibitors. 50 µl of SDS-PAGE sample buffer was
added to the beads, and the activated Ral proteins bound to GST-RID
were visualized by immunoblotting of the FLAG-tagged Ral proteins.
Coimmunoprecipitation--
293T cells were cotransfected with 2 µg of pFLAG-CMV2-RalGPS 1B and 2 µg of either pCGN-Grb2 or -Nck
using 15 µl of NovaFECTOR/100-mm dish. After 72 h the cells were
lysed in 1 ml of Ral buffer. Cellular debris was removed by a 3 min,
13,000 × g spin, and the cellular lysate was
precleared for 15 min at 4 °C with 30 µl of protein A/G-Sepharose
(Santa Cruz Biotechnology, Inc.). The precleared lysate was tumbled
with 3 µl of M2 anti-FLAG antibody (Sigma) for 5 h at 4 °C.
The immunocomplex was precipitated by a 30-min incubation with 50 µl
of protein A/G-Sepharose. The Grb2 and Nck proteins that coprecipitated
with Flag-RalGPS 1B were visualized by immunoblotting with anti-HA
antibody (Babco) following SDS-PAGE. Levels of RalGPS 1B expression
were determined by M2 anti-FLAG antibody using ECL reagents
(Amersham Pharmacia Biotech).
RalGPS Represents a Novel Family of Putative Ras GEFs--
The
catalytic (CDC25 homology) domains of Ras family GEFs share ~30%
homology with each other. Highest sequence homology is found within
SCRs (structurally conserved regions) 1-3 as defined in Ref. 8. Using
a consensus SCR2 sequence supplemented with GRF1 residues at positions
of low homology, we searched the EST database and identified several
novel putative GEF sequences. One of these, AA121710, was obtained,
sequenced, and found to encode the C-terminal portion of a CDC25
homology domain, as well as a proline-rich region similar to SH3
binding motifs, a pleckstrin homology domain, a stop codon, and a 3'
non-coding region (Fig. 1). This protein
is referred to as RalGPS 1A. Using 5' RACE we obtained the core
catalytic domain (SCRs 1-3) but could not isolate SCR0 (also known as
REM, Ras exchange motif or the conserved non-catalytic domain (15)), an
additional N-terminal domain found in most GEFs and shown in the Sos1
crystal structure to play a role in maintaining the conformation of the
catalytic domain (16). Subsequently an additional full-length sequence, KIAA0351 (accession number AB002349), which encoded a splice variant of
RalGPS 1A, referred to subsequently here as RalGPS 1B, was entered in
the NCBI database. The 5' end of this clone extended beyond our 1A
sequence and revealed a stop codon 5' to a potential initiating ATG.
This indicated that like the yeast GEF, BUD5, the RalGPS proteins do
not contain the SCR0 domain (15). RalGPS 1B contained an extra 8-amino
acid insertion within loop 3 of its PH domain, a shorter, alternate C
terminus, and a unique 69-amino acid central portion that replaced 27 amino acids in RalGPS 1A (Fig. 1A). An additional mouse
sequence, AA110466, appears to represent a novel family member, RalGPS
2 (Fig. 1B), because a closely related partial human
sequence (AA252781) is also present in the database. The AA110466
partial cDNA was obtained and sequenced and found to similarly
contain a PH domain (Fig. 1C) and PXXP motif.
SCRs 1-3 were originally defined primarily using yeast Ras GEF
sequences (8). Alignment with subsequently identified mammalian GEF
sequences has revealed two other regions of high homology that are
indicated as SCRs 4 and 5 in Fig. 1B. Interestingly, SCR4, a
highly conserved I/VNF motif has been reported to sit within a small
hydrophobic groove formed by the SCR0 domain in the Sos1 crystal
structure (16). Because SCR0 is absent from RalGPS, it is not
surprising that charged residues (ENE) occupy the place of the INF
motif of Sos1 (Fig. 1B). Further, RalGPS family members do
not have the extension in SCR3 characteristic of the RalGDS
family of Ral GEFs (Fig. 1B).
Splice Variants of RalGPS 1 Are Differentially Expressed--
A
1.5-kb XbaI-XhoI fragment of AA121710
encompassing most of the RalGPS 1A/B coding region was used to probe a
human multitissue Northern blot to examine mRNA expression. Three
bands were observed (Fig. 2), presumably
because of alternate splicing of the message. Because the full-length
KIAA0351 cDNA is 6336 base pairs in length, RalGPS 1B likely
represents the middle, ~7-kb band that is ubiquitously expressed.
Assuming that RalGPS 1A and B have identical 5' ends the 1A message is
predicted to be ~2 kb and is therefore represented by the lower,
2.6-kb blot band that was preferentially expressed in heart and testis.
The identity of the larger ~12-kb doublet was not established.
Therefore, similarly to GRF1 (17), there are multiple spliced variants
of the RalGPS GEFs that are differentially expressed in human
tissues.
RalGPS 1 Is a Ral-specific GEF--
To identify Ras substrates for
RalGPS 1A and B, we first assessed their ability to bind a panel of
nucleotide-free GTPases. Because GEFs bind with high affinity to Ras
proteins in the absence of Mg2+/GTP or GDP and stabilize
the nucleotide-free state (2), epitope-tagged RalGPS 1 proteins
expressed in 293T cells were incubated with GST-Ras fusion proteins
that had been stripped of GDP in the presence of EDTA. As shown in Fig.
3A, nucleotide-free Ral but
not other GTPases or GST bound to both RalGPS 1 splice variants.
To confirm that the interaction of RalGPS with Ral resulted in
nucleotide exchange we examined the ability of RalA to be loaded with
GTP in vivo following cotransfection with known and putative Ral GEFs. For these assays we took advantage of the fact that the
putative Ral effector RalBP1 binds preferentially to Ral-GTP versus Ral-GDP to specifically extract activated Ral from
cell lysates (18, 19). As can be seen in Fig. 3B, there was
little Ral-GTP present in serum-starved 293T cells. However, following co-transfection with the RalGDS family member Rlf or with RalGPS 1B,
Ral-GTP levels were increased by an equivalent amount, indicating that
RalGPS was indeed a Ral GEF. Because a trace of Rap1A binding to RalGPS
was detected in some assays (see Fig. 3A), we examined the
Ras protein nucleotide exchange specificity of RalGPS. Using a GST
fusion protein containing the Ras/Rap1-GTP-binding domain of cellular
Raf1 to precipitate activated Rap1A from cell lysates we found that
cotransfection with RalGPS 1B failed to activate Rap1A under conditions
where the known Rap1 GEF, C3G, promoted significant accumulation of
Rap1A-GTP in vivo. Taken together, the data in Fig. 3,
A and B indicate that RalGPS 1 is a highly specific Ral GEF. We have not confirmed that RalGPS 2 is also a Ral
GEF, but given the high degree of sequence conservation with RalGPS
1A/B within its catalytic domain (Fig. 1B) this seems likely.
The PH Domain of RalGPS Is Required for Biological
Activity--
PH domains are typically involved in protein-protein or
protein-lipid interactions (10). For example, the PH domains of the
As shown in Fig. 3C, this deletion completely abrogated the
ability of overexpressed RalGPS 1B to activate Ral in vivo.
To address whether the PH domain might be responsible for interaction of the GEF with the plasma membrane, it was replaced with the C-terminal 18 residues of Ki-Ras that we and others have previously reported will target heterologous proteins to the plasma membrane (24,
25). Upon addition of this Ras CAAX sequence to
RalGPS- The RalGPS 1 Proline-rich Motif Binds to Grb2 and Nck and
Facilitates Adapter Protein-mediated Activation of Ral--
As shown
in Fig. 4A, the proline-rich
motif present in RalGPS 1A/B bears sequence homology with the SH3
binding motifs of the Grb2 and Nck adapter protein targets, Sos1 and
PAK. In addition to the core PXXP motif, there are
surrounding proline residues to form a left-handed P3 helix plus
adjacent arginine residues that help orient the peptide and confer
binding specificity (9). Indeed the proline-rich region in RalGPS
matches consensus sequences derived for Grb2 and Nck SH3 binding
peptides by phage-displayed random peptide libraries (9, 14). To
examine the ability of RalGPS 1 to bind to SH3 domain-containing
proteins in vitro, FLAG-tagged RalGPS 1B was expressed in
293T cells and cell lysates incubated with GST fusion proteins
containing the SH3 domains of various proteins. As seen in Fig.
4B, RalGPS 1B was precipitated by SH3 domains from Grb2,
Nck, Src, and PLC
It is well documented that Grb2 contributes to the recruitment of the
Ras GEF, Sos1, to the plasma membrane, leading to Ras activation (2)
and that the Sos PH domain also plays a role in this process (29).
Association of Grb2 with Sos may also alleviate negative allosteric
control imparted by the Sos C terminus (25, 30). Although
over-expression of Grb2 did not enhance the ability of recombinant
RalGPS to activate Ral in vivo (Fig. 4), we rationalized
that the adapter protein/GEF interaction likely contributes to the
physiological regulation of RalGPS. Because RalGPS did not activate Ral
following removal of the GEF's PH domain, we examined whether
over-expression of Grb2 might enhance the activity of this
In conclusion, we have identified a novel family of putative GEFs that
includes at least two members plus differentially expressed splice
variants. RalGPS 1 specifically associated with and activated the
Ras-related GTPase, Ral, when overexpressed in 293T cells. In contrast
to the RalGDS family of Ral GEFs that rely on interaction with Ras-GTP
for membrane translocation and Ral activation (27), but similarly to
the Ras GEF, Sos1 (30), RalGPS 1 nucleotide exchange activity is
regulated in vivo by a PH domain and a Grb2-binding PXXP motif. Although Ca2+ has been reported to
activate Ral in a Ras-independent manner (31) there is no indication
from their primary sequences that RalGPS 1A/B could respond to
Ca2+ elevation. Why nature has created so many Ral GEFs and
how they are differentially regulated will be the topics of future investigation.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
PH-CAAX was then directionally ligated into the
BamHI site of pFLAG-CMV2.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

View larger version (95K):
[in a new window]
Fig. 1.
Structure and alignment of RalGPS exchange
factors. A, model of RalGPS 1A and B open reading
frames showing the position of the catalytic domain, proline-rich
PXXP motif, and PH domain. The positions of sequence
differences in the 1B splice variant are shown in black.
Numbers indicate the extent of amino acid divergence between
the 1A (left) and B (right) splice variants.
B, sequence alignment of GEF domains from human RalGPS 1A/B
(AB002349) and a partial mouse RalGPS 2 clone (AA110466) with Ral GEFs
(mouse RalGDS, L07924; mouse Rgl, U14103; mouse Rlf, U54639; and rabbit
Rsc, U82163), Ras GEFs (human Sos1, L13857 and rat GRF1, X67241), and
the Rap1 GEF, C3G (human, D21239). Sequences were aligned using Clustal
W with subsequent manual adjustment. Similarities were highlighted
using MacBoxshade. C, sequence alignment of RalGPS PH
domains with the N-terminal PH domains of Tiam-1 (Q60610), Still life 1 (P91621), pleckstrin (P08567), and GRF1 (X67241). A potential
phosphorylation site in RalGPS 1B is underlined.

View larger version (61K):
[in a new window]
Fig. 2.
Multitissue Northern blot showing RalGPS 1A/B
distribution. An ~1.5-kb XbaI-XhoI
fragment encompassing most of the RalGPS 1A coding region was used to
screen a human multitissue Northern blot essentially as described by
the manufacturer. Two bands were predicted to be RalGPS 1A and B based
on the sizes of their respective cDNAs. skel. muscle,
skeletal muscle; sm. intestine, small intestine;
m.l., mucosal lining; p.b., peripheral
blood.

View larger version (39K):
[in a new window]
Fig. 3.
RalGPS 1 is a Ral GEF that requires membrane
targeting to function in vivo. A, the indicated
GST-Ras fusion proteins (20 µg) were stripped of nucleotide and used
to precipitate FLAG-tagged RalGPS 1A or B from 293T cell lysates. Bound
GEFs were detected by Western blotting precipitates with M2 anti-FLAG
antibody. B, empty vector or vectors encoding RalGPS 1B, the
Ral GEF, Rlf, or the Rap1 GEF, C3G were cotransfected into 293T cells
with vectors encoding FLAG-tagged RalA or Rap1A as indicated. Following
overnight serum starvation, cells were lysed, and RalA-GTP and
Rap1A-GTP were extracted by incubation with the GTPase-binding domains
of RalBP1 and cellular Raf1, respectively. Stimulation of Ral/Rap1-GTP
accumulation was determined by Western blotting with anti-FLAG
antibody. Lower panels demonstrate equal GTPase transfection
levels under each condition by Western blotting cell lysates for FLAG
Ral or Rap1. C, 293T cells were transfected with vectors
encoding FLAG-tagged RalA ± the indicated FLAG-tagged Ral GEFs.
Deletion of the PH domain (RalGPS-
PH) resulted in loss of in
vivo exchange activity, whereas attachment of the Ki-Ras C
terminus (RalGPS-
PH-CAAX) resulted in its restoration.
All data are representative of at least three independent
experiments.
-adrenergic receptor kinase and GRF bind to the 
subunits of
heterotrimeric G proteins (20), whereas most PH domains associate with
the polyphosphoinositides, phosphatidylinositol 4,5 bisphosphate and phosphatidylinositol 1,4,5-trisphosphate (PIP3) (21).
Comparison of the RalGPS PH domain with that of other molecules
demonstrated strongest identity with the N-terminal PH domains of
Tiam-1 and the Drosophila melanogaster Still life (Fig.
1C), GEFs that regulate Rho family GTPases (22, 23). It has
been reported that the Tiam-1 N-terminal PH domain binds to
PIP3 (21) and is required for membrane association and
biological activity of this Rac GEF (23). Therefore, we deleted the PH
domain from RalGPS 1B (RalGPS-
PH) and examined the consequence of
this modification on in vivo GEF activity.
PH, we rescued its ability to promote Ral-GTP accumulation
in vivo (Fig. 3C), suggesting that the role of
the PH domain was indeed membrane targeting. It has previously been
established that Ras is responsible for the recruitment of RalGDS
family members to the plasma membrane and that this membrane targeting
is essential for GEF activity (26, 27). The RA domain responsible for
RalGDS association with Ras-GTP (11, 12) is absent from the RalGPS family and is presumably replaced in RalGPS by the PH domain. We have
not established whether the sequence difference between RalGPS 1A and B
in loop 3 of the PH domain affects their ligand specificity or
function. However, the sequence of RalGPS 1B includes a consensus
phosphorylation site for the cyclic AMP-dependent protein
kinase (KKVSI (28), underlined in Fig. 1C). Introduction of
a negatively charged phosphate group at this site could inhibit binding
of the PH domain to PIP3. Although full-length RalGPS 1A
was expressed poorly in 293T cells, RalGPS 1A-
PH-CAAX
activated Ral as effectively as its 1B
counterpart.2
but not those of p120 Ras GAP, Crk, Abl, or
p67phox. To determine whether the interactions with adapter
proteins might occur in vivo, 293T cells were co-transfected
with plasmids encoding FLAG-tagged RalGPS 1B and HA-tagged Grb2 or Nck.
Following lysis and precipitation with anti-FLAG antibody, both Grb2
and Nck were found to coprecipitate with RalGPS (Fig.
4C).

View larger version (43K):
[in a new window]
Fig. 4.
The RalGPS 1 PXXP motif is
required for Grb2 and Nck SH3 domain binding and regulation.
A, alignment of proline-rich motifs that bind to the
N-terminal Grb2 or central Nck SH3 domains. B, the ability
of FLAG-RalGPS 1B to bind to SH3 domains in vitro was
determined by incubating 293T cell lysates with equal amounts of
glutathione-agarose bead-immobilized GST fusion proteins containing
full-length Grb2, the SH3 domains of Nck, the isolated SH3 domains from
p120 Ras GAP, Abl, Src, and phospholipase C
, or the N-terminal SH3
domains from Crk and p67phox. Beads were washed, and
associated RalGPS was detected by Western blotting. C, to
determine whether RalGPS could interact with SH3-containing adapter
proteins in vivo, 293T cells were cotransfected with empty
vector or vector encoding FLAG-RalGPS 1B, HA-Grb2, or HA-Nck as
indicated. Following immunoprecipitation with anti-FLAG antibody,
associated adapter proteins were detected by blotting with anti-HA
antibody. Lower panels demonstrate expression levels of
RalGPS, Grb2, and Nck in cell lysates. HC and LC
indicate heavy and light chains, respectively, of the M2 anti-FLAG
antibody. D, RalGPS-
PH is activated by Grb2. 293T cells
were cotransfected with plasmids encoding FLAG-RalA, RalGPS-
PH, and
Grb2 as indicated. After serum starving over night cell lysates were
prepared, and RalA-GTP was precipitated using GST-RalBP1(10 µg) and
detected by Western blotting. All data are representative of at least
three independent experiments.
PH
mutant. As seen in Fig. 4D, co-transfection with Grb2 did
indeed promote Ral activation by RalGPS-
PH, indicating that, as
described for Sos1, growth factor stimulation may be responsible for
promoting the translocation and/or activation of RalGPS. Because Grb2
alone did not promote Ral-GTP accumulation we can conclude that this
effect was dependent on the presence of transfected RalGPS and was not
due to activation of an endogenous Grb2>Sos>Ras>RalGDS>Ral pathway.
This notion was further supported by failure of a dominant inhibitory
Ras(17A) mutant to block the ability of Grb2 to activate Ral in the
presence of RalGPS-
PH.2 Although Ras could potentially
modulate full-length RalGPS activity in vivo via a
PI3K-PIP3 pathway, surprisingly, we did not see an effect
of a PI3K inhibitor (LY294002, 30 µM) on Ral activation by this GEF. As seen in Fig. 4A, RalGPS 2 deviates from 1A
and B in residues surrounding the PXXP motif. Whether this
deviation affects the ability of RalGPS 2 to differentially interact
with SH3 domain-containing adapter proteins will require further investigation.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Chen Bi for tissue culture support and to Drs. Doug Andres, Geoff Clark, and Hidesuburo Hanafusa for plasmids.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant CA63139 and American Cancer Society Grants RPG 97-007-01-BE and RPG-00-125-01-TBE to LAQ.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF221098.
To whom correspondence should be addressed: Dept. of Biochemistry
and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Dr., MS-4053, Indianapolis, IN 46202. Tel.: 317-274-8550; Fax:
317-274-4686; E-mail: lquillia@iupui.edu.
Published, JBC Papers in Press, March 15, 2000, DOI 10.1074/jbc.C000085200
2 J. F. Rebhun and L. A. Quilliam, unpublished observation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: GEF(s), guanine nucleotide exchange factor(s); PH, pleckstrin homology; SH, Src homology; RalGPS, Ral GEF with PH and SH3-binding domains; GAP(s) GTPase-activating protein(s), EST, expressed sequence tag; RACE, rapid amplification of cDNA ends; PMSF, phenylmethylsulfonyl fluoride; GST, glutathione S-transferase; TIU, trypsin inhibitory units; DTT, dithiothreitol; kb, kilobase pair; PAGE, polyacrylamide gel electrophoresis; SCR(s), structurally conserved region(s); RalGDS, Ral guanine nucleotide dissociation stimulator; RA, RalGDS/AF6 homology or Ras-associated domain; RID, Ral interacting domain; PIP3, phosphatidylinositol 1,4,5-trisphosphate; PI3K, phosphatidylinositol 3-kinase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Campbell, S. L., Khosravi-Far, R., Rossman, K. L., Clark, G. J., and Der, C. J. (1998) Oncogene 17, 1395-1413 |
| 2. | Quilliam, L. A., Khosravi-Far, R., Huff, S. Y., and Der, C. J. (1995) Bioessays 17, 395-404 |
| 3. | Bos, J. L. (1998) EMBO J. 17, 6776-6782 |
| 4. | de Rooij, J., Zwartkruis, F. J., Verheijen, M. H., Cool, R. H., Nijman, S. M., Wittinghofer, A., and Bos, J. L. (1998) Nature 396, 474-477 |
| 5. | Ebinu, J. O., Bottorff, D. A., Chan, E. Y., Stang, S. L., Dunn, R. J., and Stone, J. C. (1998) Science 280, 1082-1086 |
| 6. | Gotoh, T., Niino, Y., Tokuda, M., Hatase, O., Nakamura, S., Matsuda, M., and Hattori, S. (1997) J. Biol. Chem. 272, 18602-18607 |
| 7. | Kawasaki, H., Springett, G. M., Toki, S., Canales, J. J., Harlan, P., Blumenstiel, J. P., Chen, E. J., Bany, I. A., Mochizuki, N., Ashbacher, A., Matsuda, M., Housman, D. E., and Graybiel, A. M. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 13278-13283 |
| 8. | Boguski, M. S., and McCormick, F. (1993) Nature 366, 643-654 |
| 9. | Sparks, A. B., Rider, J. E., Hoffmann, N. G., Fowlkes, D. M., Quilliam, L. A., and Kay, B. K. (1996) Proc. Natl. Acad. Sci. U. S. A. 93 |
| 10. | Lemmon, M. A., and Ferguson, K. M. (1998) Curr. Top. Microbiol. Immunol. 228, 39-74 |
| 11. | Wojcik, J., Girault, J. A., Labesse, G., Chomilier, J., Mornon, J. P., and Callebaut, I. (1999) Biochem. Biophys. Res. Commun. 259, 113-120 |
| 12. | Ponting, C. P., and Benjamin, D. R. (1996) Trends Biochem. Sci. 21, 422-425 |
| 13. | Braverman, L. E., and Quilliam, L. A. (1999) J. Biol. Chem. 274, 5542-5549 |
| 14. | Quilliam, L. A., Lambert, Q. T., Mickelson-Young, L. A., Westwick, J. K., Sparks, A. B., Kay, B. K., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., and Der, C. J. (1996) J. Biol. Chem. 271, 28772-28776 |
| 15. | Lai, C. C., Boguski, M., Broek, D., and Powers, S. (1993) Mol. Cell. Biol. 13, 1345-1352 |
| 16. | Boriack-Sjodin, P. A., Margarit, S. M., Bar-Sagi, D., and Kuriyan, J. (1998) Nature 394, 337-343 |
| 17. | Cen, H., Papageorge, A. G., Zippel, R., Lowy, D. R., and Zhang, K. (1992) EMBO J. 11, 4007-4015 |
| 18. | Cantor, S. B., Urano, T., and Feig, L. A. (1995) Mol. Cell. Biol. 15, 4578-4584 |
| 19. | Wolthuis, R. M., Franke, B., van Triest, M., Bauer, B., Cool, R. H., Camonis, J. H., Akkerman, J. W., and Bos, J. L. (1998) Mol. Cell. Biol. 18, 2486-2491 |
| 20. | Touhara, K., Inglese, J., Pitcher, J. A., Shaw, G., and Lefkowitz, R. J. (1994) J. Biol. Chem. 269, 10217-10220 |
| 21. | Rameh, L. E., Arvidsson, A., Carraway, K. L., III, Couvillon, A. D., Rathbun, G., Crompton, A., VanRenterghem, B., Czech, M. P., Ravichandran, K. S., Burakoff, S. J., Wang, D. S., Chen, C. S., and Cantley, L. C. (1997) J. Biol. Chem. 272, 22059-22066 |
| 22. | Sone, M., Hoshino, M., Suzuki, E., Kuroda, S., Kaibuchi, K., Nakagoshi, H., Saigo, K., Nabeshima, Y., and Hama, C. (1997) Science 275, 543-547 |
| 23. | Michiels, F., Stam, J. C., Hordijk, P. L., van der Kammen, R. A., Ruuls-Van Stalle, L., Feltkamp, C. A., and Collard, J. G. (1997) J. Cell Biol. 137, 387-398 |
| 24. | Quilliam, L. A., Huff, S. Y., Rabun, K. M., Wei, W., Park, W., Broek, D., and Der, C. J. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8512-8516 |
| 25. | Aronheim, A., Engelberg, D., Li, N., al-Alawi, N., Schlessinger, J., and Karin, M. (1994) Cell 78, 949-961 |
| 26. | Wolthuis, R. M., de Ruiter, N. D., Cool, R. H., and Bos, J. L. (1997) EMBO J. 16, 6748-6761 |
| 27. | Matsubara, K., Kishida, S., Matsuura, Y., Kitayama, H., Noda, M., and Kikuchi, A. (1999) Oncogene 18, 1303-1312 |
| 28. | Kemp, B. E., and Pearson, R. B. (1990) Trends. Biochem. Sci. 15, 342-346 |
| 29. | Chen, R. H., Corbalan-Garcia, S., and Bar-Sagi, D. (1997) EMBO J. 16, 1351-1359 |
| 30. | Corbalan-Garcia, S., Margarit, S. M., Galron, D., Yang, S. S., and Bar-Sagi, D. (1998) Mol. Cell. Biol. 18, 880-886 |
| 31. | Hofer, F., Berdeaux, R., and Martin, G. S. (1998) Curr. Biol. 8, 839-842 |
| 32. | Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T., and Bowtell, D. (1993) Nature 363, 83-85 |
| 33. | Bokoch, G. M., Wang, Y., Bohl, B. P., Sells, M. A., Quilliam, L. A., and Knaus, U. G. (1996) J. Biol. Chem. 271, 25746-25749 |
This article has been cited by other articles:
![]() |
Y. Sun, Y. Fang, M.-S. Yoon, C. Zhang, M. Roccio, F. J. Zwartkruis, M. Armstrong, H. A. Brown, and J. Chen Phospholipase D1 is an effector of Rheb in the mTOR pathway PNAS, June 17, 2008; 105(24): 8286 - 8291. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ura, K. Obama, S. Satoh, Y. Sakai, Y. Nakamura, and Y. Furukawa Enhanced RASGEF1A Expression Is Involved in the Growth and Migration of Intrahepatic Cholangiocarcinoma. Clin. Cancer Res., November 15, 2006; 12(22): 6611 - 6616. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Blanke and H. Jackle Novel guanine nucleotide exchange factor GEFmeso of Drosophila melanogaster interacts with Ral and Rho GTPase Cdc42 FASEB J, April 1, 2006; 20(6): 683 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shipitsin and L. A. Feig RalA but Not RalB Enhances Polarized Delivery of Membrane Proteins to the Basolateral Surface of Epithelial Cells Mol. Cell. Biol., July 1, 2004; 24(13): 5746 - 5756. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Rondaij, E. Sellink, K. A. Gijzen, J. P. ten Klooster, P. L. Hordijk, J. A. van Mourik, and J. Voorberg Small GTP-Binding Protein Ral Is Involved in cAMP-Mediated Release of von Willebrand Factor From Endothelial Cells Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1315 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takaya, Y. Ohba, K. Kurokawa, and M. Matsuda RalA Activation at Nascent Lamellipodia of Epidermal Growth Factor-stimulated Cos7 Cells and Migrating Madin-Darby Canine Kidney Cells Mol. Biol. Cell, June 1, 2004; 15(6): 2549 - 2557. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Madani, A. Hichami, M. Charkaoui-Malki, and N. A. Khan Diacylglycerols Containing Omega 3 and Omega 6 Fatty Acids Bind to RasGRP and Modulate MAP Kinase Activation J. Biol. Chem., January 9, 2004; 279(2): 1176 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hernandez-Munoz, M. Benet, M. Calero, M. Jimenez, R. Diaz, and A. Pellicer rgr Oncogene: Activation by Elimination of Translational Controls and Mislocalization Cancer Res., July 15, 2003; 63(14): 4188 - 4195. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Ascano, L. J. Beverly, and A. J. Capobianco The C-terminal PDZ-Ligand of JAGGED1 Is Essential for Cellular Transformation J. Biol. Chem., February 28, 2003; 278(10): 8771 - 8779. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mirey, M. Balakireva, S. L'Hoste, C. Rosse, S. Voegeling, and J. Camonis A Ral Guanine Exchange Factor-Ral Pathway Is Conserved in Drosophila melanogaster and Sheds New Light on the Connectivity of the Ral, Ras, and Rap Pathways Mol. Cell. Biol., February 1, 2003; 23(3): 1112 - 1124. [Abstract] [Full Text] |
||||
![]() |
E. MARTEGANI, M. CERIANI, R. TISI, and G. BERRUTI Cloning and Characterization of a New Ral-GEF Expressed in Mouse Testis Ann. N.Y. Acad. Sci., November 1, 2002; 973(1): 135 - 137. [Full Text] [PDF] |
||||
![]() |
G. W. Reuther, Q. T. Lambert, J. F. Rebhun, M. A. Caligiuri, L. A. Quilliam, and C. J. Der RasGRP4 Is a Novel Ras Activator Isolated from Acute Myeloid Leukemia J. Biol. Chem., August 16, 2002; 277(34): 30508 - 30514. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Hamad, J. H. Elconin, A. E. Karnoub, W. Bai, J. N. Rich, R. T. Abraham, C. J. Der, and C. M. Counter Distinct requirements for Ras oncogenesis in human versus mouse cells Genes & Dev., August 15, 2002; 16(16): 2045 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Kazanietz Novel "Nonkinase" Phorbol Ester Receptors: The C1 Domain Connection Mol. Pharmacol., April 1, 2002; 61(4): 759 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Brose and C. Rosenmund Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters J. Cell Sci., January 12, 2002; 115(23): 4399 - 4411. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rusanescu, T. Gotoh, X. Tian, and L. A. Feig Regulation of Ras Signaling Specificity by Protein Kinase C Mol. Cell. Biol., April 15, 2001; 21(8): 2650 - 2658. [Abstract] [Full Text] |
||||
![]() |
T. Gotoh, D. Cai, X. Tian, L. A. Feig, and A. Lerner p130Cas Regulates the Activity of AND-34, a Novel Ral, Rap1, and R-Ras Guanine Nucleotide Exchange Factor J. Biol. Chem., September 22, 2000; 275(39): 30118 - 30123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Rebhun, A. F. Castro, and L. A. Quilliam Identification of Guanine Nucleotide Exchange Factors (GEFs) for the Rap1 GTPase. REGULATION OF MR-GEF BY M-Ras-GTP INTERACTION J. Biol. Chem., November 3, 2000; 275(45): 34901 - 34908. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||